Delivery Order SPE2DH25D0001-SPE2D426F0718
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,691.50 by the Medical Supply Chain, a Defense agency function, on October 8, 2025. The contract, identified as METLYTE 8 PANEL, represents a fixed-price delivery order with economic price adjustment provisions and is scheduled for completion by October 10, 2025. The work will be performed in North Chicago, Illinois, where Abbott maintains its headquarters and point-of-care division....
- Abbott Laboratories Inc. has been awarded a delivery order valued at $1,904.40 for METLYTE 8 PANEL under a fixed-price contract with economic price adjustment provisions. This contract, with an ultimate completion date of August 7, 2025, was awarded on August 5, 2025, by the Defense Department's Medical Supply Chain organization. The work will be performed in North Chicago, Illinois, where Abbott maintains its global headquarters. This delivery order was awarded through full and open competition...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order for METLYTE 8 PANEL products valued at $2,461.00 on August 11, 2025, with an ultimate completion date of August 13, 2025. The contract utilizes fixed price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order was awarded without a set-aside designation, indicating full and open competition. The funding source is the Defense Medical Supply...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order for METLYTE 8 PANEL products valued at $3,570.75 on June 26, 2025, with an ultimate completion date of June 30, 2025. This fixed-price contract with economic price adjustment was awarded without a set-aside designation, indicating full and open competition. The contract is being performed in North Chicago, Illinois, and is funded by the Defense Medical Supply Chain, a defense-oriented federal...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,845.75 for the METLYTE 8 Panel on August 6, 2025, with an ultimate completion date of August 8, 2025. This fixed-price delivery order with economic price adjustment was issued without a set-aside designation, indicating full and open competition. The contract is being performed in North Chicago, Illinois, and is funded by the Defense Medical Supply Chain, a defense-focused federal...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,691.50 for the supply of METLYTE 8 Panel products under a fixed-price contract with economic price adjustment provisions. The award, issued on September 11, 2025, with an ultimate completion date of September 15, 2025, represents a non-competitive procurement without set-aside designation. The work will be performed at Abbott's facility in North Chicago, Illinois, and is funded...
- The Defense Medical Supply Chain has awarded a $1,230.50 fixed-price delivery order to Abbott Laboratories Inc.'s Point of Care division for the supply of METLYTE 8 Panel units. Awarded on August 6, 2025, with an ultimate completion date of August 8, 2025, this delivery order was issued without set-aside designation, indicating full and open competition. The product will be delivered to Abbott Laboratories' facility in North Chicago, Illinois, where the company manufactures its comprehensive...
- Abbott Laboratories Inc.'s Point of Care division received a $1,150 delivery order award from the Defense Logistics Agency's Medical Supply Chain on October 20, 2025, for a Comprehensive Metabolic Panel with an ultimate completion date of October 22, 2025. This fixed-price contract with economic price adjustment features no small business set-aside and will be performed in North Chicago, Illinois, where Abbott maintains its corporate headquarters and primary operations. The delivery order...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,389.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025, with an ultimate completion date of October 29, 2025. This fixed-price delivery order with economic price adjustment provisions was issued under a larger indefinite delivery vehicle and is to be performed in North Chicago, Illinois. The contract was awarded without a set-aside designation, reflecting full...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,041.75 on October 1, 2025, by the Defense Medical Supply Chain agency. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a call against an existing contract vehicle and will be performed in North Chicago, Illinois. The award was made through full and open competition with no set-aside designation applied. The delivery order falls under...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D426F0718Delivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a fixed-price delivery order valued at $1,230.50 on October 30, 2025, for the METLYTE 8 PANEL, with an ultimate completion date of November 3, 2025. The contract was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation and will be performed in North Chicago, Illinois, where Abbott maintains its headquarters. The pricing structure includes economic price adjustment provisions, enabling flexible cost management aligned with market conditions. This delivery order represents a task order issued against Abbott's existing indefinite delivery vehicle portfolio with the Defense Logistics Agency Medical Supply Chain, through which the company supplies consumable diagnostic products and medical testing supplies to the Department of Defense healthcare system. Abbott's extensive presence in federal medical procurement, supported by multiple blanket purchase agreements across Veterans Integrated Service Networks and Defense Health Agency contracts, demonstrates its established capability as a primary supplier of clinical laboratory analyzers, point-of-care testing equipment, and diagnostic reagents. The METLYTE 8 PANEL delivery falls within Abbott's core business of providing chemistry and immunoassay testing supplies that support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/30/25 |